Answers are grounded in this paper and cite their sources.
Increasing numbers of countries are considering cost effectiveness in decisions about which drugs to make available for prescription. How do the different approaches work and is it time for standardisation?
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: